Cell-Free DNA Methylation as Blood-Based Biomarkers for Pancreatic Adenocarcinoma—A Literature Update

Pancreatic adenocarcinoma has a horrible prognosis, which is partly due to difficulties in diagnosing the disease in an early stage. Additional blood-born biomarkers for pancreatic adenocarcinoma are needed. Epigenetic modifications, as changes in DNA methylation, is a fundamental part of carcinogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Henriksen, Stine Dam, Thorlacius-Ussing, Ole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594668/
https://www.ncbi.nlm.nih.gov/pubmed/34968295
http://dx.doi.org/10.3390/epigenomes5020008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594668/
https://www.ncbi.nlm.nih.gov/pubmed/34968295
http://dx.doi.org/10.3390/epigenomes5020008

Ejemplares similares